Similar articles for PMID: 20008986

Year	Number of Results
2001	2
2003	1
2004	3
2006	2
2007	6
2008	6
2009	11
2010	12
2011	12
2012	11
2013	14
2014	16
2015	25
2016	23
2017	25
2018	20
2019	27
2020	28
2021	32
2022	26
2023	13
2024	0

1

A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer.

Hwang DW, Ko HY, Lee JH, Kang H, Ryu SH, Song IC, Lee DS, Kim S. Hwang DW, et al. J Nucl Med. 2010 Jan;51(1):98-105. doi: 10.2967/jnumed.109.069880. Epub 2009 Dec 15. J Nucl Med. 2010. PMID: 20008986 Free article.

2

Multimodal imaging probe for targeting cancer cells using uMUC-1 aptamer.

Kang WJ, Lee J, Lee YS, Cho S, Ali BA, Al-Khedhairy AA, Heo H, Kim S. Kang WJ, et al. Colloids Surf B Biointerfaces. 2015 Dec 1;136:134-40. doi: 10.1016/j.colsurfb.2015.09.004. Epub 2015 Sep 5. Colloids Surf B Biointerfaces. 2015. PMID: 26387066

3

Development of a quadruple imaging modality by using nanoparticles.

Hwang DW, Ko HY, Kim SK, Kim D, Lee DS, Kim S. Hwang DW, et al. Chemistry. 2009 Sep 21;15(37):9387-93. doi: 10.1002/chem.200900344. Chemistry. 2009. PMID: 19658128

4

Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.

Noaparast Z, Hosseinimehr SJ, Piramoon M, Abedi SM. Noaparast Z, et al. J Drug Target. 2015;23(6):497-505. doi: 10.3109/1061186X.2015.1009075. Epub 2015 Feb 12. J Drug Target. 2015. PMID: 25673264

5

Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.

Alibolandi M, Taghdisi SM, Ramezani P, Hosseini Shamili F, Farzad SA, Abnous K, Ramezani M. Alibolandi M, et al. Int J Pharm. 2017 Mar 15;519(1-2):352-364. doi: 10.1016/j.ijpharm.2017.01.044. Epub 2017 Jan 23. Int J Pharm. 2017. PMID: 28126548

6

Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle.

Kim JK, Choi KJ, Lee M, Jo MH, Kim S. Kim JK, et al. Biomaterials. 2012 Jan;33(1):207-17. doi: 10.1016/j.biomaterials.2011.09.023. Epub 2011 Sep 23. Biomaterials. 2012. PMID: 21944470

7

Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.

Mosafer J, Mokhtarzadeh A. Mosafer J, et al. Curr Drug Deliv. 2018;15(9):1323-1329. doi: 10.2174/1567201815666180724104451. Curr Drug Deliv. 2018. PMID: 30039760

8

A multimodal nanoparticle-based cancer imaging probe simultaneously targeting nucleolin, integrin αvβ3 and tenascin-C proteins.

Ko HY, Choi KJ, Lee CH, Kim S. Ko HY, et al. Biomaterials. 2011 Feb;32(4):1130-8. doi: 10.1016/j.biomaterials.2010.10.034. Epub 2010 Nov 10. Biomaterials. 2011. PMID: 21071077

9

G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms.

Bates PJ, Reyes-Reyes EM, Malik MT, Murphy EM, O'Toole MG, Trent JO. Bates PJ, et al. Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt B):1414-1428. doi: 10.1016/j.bbagen.2016.12.015. Epub 2016 Dec 20. Biochim Biophys Acta Gen Subj. 2017. PMID: 28007579 Review.

10

Aptamer-mediated synthesis of multifunctional nano-hydroxyapatite for active tumour bioimaging and treatment.

Zhang W, Zhou R, Yang Y, Peng S, Xiao D, Kong T, Cai X, Zhu B. Zhang W, et al. Cell Prolif. 2021 Sep;54(9):e13105. doi: 10.1111/cpr.13105. Epub 2021 Aug 12. Cell Prolif. 2021. PMID: 34382270 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

280 results

Results by year